Stay updated on Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    A new page revision tag, v3.5.4, was added to the history, replacing the previous tag, v3.5.3. This indicates a version update to the page rendering rather than changes to the study data or text.
    Difference
    0.1%
    Check dated 2026-05-14T23:00:45.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.3) has been added to the Record History. The previous revision (v3.5.2) has been removed.
    Difference
    0.1%
    Check dated 2026-04-30T18:50:34.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.2 and the v3.5.0 revision was removed.
    Difference
    0.1%
    Check dated 2026-04-16T11:07:49.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed from the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T19:19:55.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added and Revision: v3.4.2 has been removed from the history.
    Difference
    0.1%
    Check dated 2026-03-11T17:20:47.000Z thumbnail image
  9. Check
    113 days ago
    Change Detected
    Summary
    A new site revision (v3.4.2) was added and a prior funding notice (v3.4.1) removed; these administrative changes do not affect the study record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T09:21:01.000Z thumbnail image

Stay in the know with updates to Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.